orthopedics, physiotherapy, sports medicine urology
Sports Medicine Rehabilitation Traumatology and Rheumatology
500 Unit/Units per Month Orthopaedic and Sports Medicine Specialists Shock Wave Therapy
Packaging & Delivery
aluminium carry case or wood case for Orthopaedic and Sports Medicine Specialists Shock Wave Therapy Device
Orthopaedic and Sports Medicine Specialists Shock Wave Therapy Device
Mini Shockwave therapy system Model : BS-SWT2X
SmartWave Shock Wave Therapy Equipment
Shock Wave Therapy Equipment, Radial Pulse Therapy (RSWT), ESWT extracorporeal shockwave therapy, also called Acoustic Wave Therapy Equipment, mainly for physical therapy treatment, sports injury and rehabitation treatment. A Non-Invasive Alternative to Orthopedic Surgery for tendon, musculoskeletal, soft tissue issues, non-union fractures to promote revascularization healing.
BS-SWT2X SMARTWAVE uses the latest electric-magnetic technology, without air-compressor, so comes with longer lifecycle, at the same time it can provide higher energy and frequency for better treatment result. From technical view, BS-SWT2X can reach energy from 10mJ (0.25Bar) to 190mJ (5Bar), adjustable at stepping 10mJ(0.25Bar). Frequency ranges from 1Hz to 22Hz adjustable.
From the view of transmitter, BS-SWT2X Smartwave has 5 different alloy made transmitters targeting to different depth and treatment disease.It includes 6mm, 15mm, 15mm unfocused, 25mm, 36mm,which covers most applications for physical treatments as well as aesthetics treatments.
What is EPAT?
Extracorporeal pulse activation treatment (EPAT) is the most advanced and highly effective noninvasive treatment method approved by the FDA to treat acute or chronic muscle and tendon pain by stimulating blood circulation and accelerating the healing process. Damaged tissue gradually regenerates and eventually heals. Patients with heel pain (plantar fasciitis) or other tendon pain like Achilles tendonitis can benefit from this treatment.
How does EPAT work? The treatment utilizes a unique set of acoustic pressure waves that are delivered through the body and focused on the site of pain/injury with a special applicator. These pressure waves stimulate the metabolism, enhance blood circulation and accelerate the healing process.
SHOCKWAVE THERAPY HIGHLY EFFECTIVE PAIN TREATMENT
Extracorporeal Pulse Activation Technology (EPAT) Today, physicians are interested in making an investment in advanced technology only if it will help them provide better care, at a lower cost, with more positive outcomes than previously realized. Physicians, like you, who regularly treat patients with acute or chronic musculoskeletal pain will want to consider learning more about the advantages of Extracorporeal Pulse Activation Technology (EPAT) and adding it to your continuum of care. Smartwave EPAT helps treat patients who suffer from overuse or soft tissue injuries and is a proven non-invasive alternative to traditional treatment methods, including surgery. EPAT technology and smartwave devices improve the regenerative potential, rather than further damaging an area that has degenerated because of poor blood flow, tissue injury, overuse or weakness. With EPAT, you are treating the root cause of your patients’ pain, not just the symptoms, and helping them get better faster–with no downtime.
Advantage and Specification of SmartWave:
Long lifespan acoustic wave applicator, over 3 million shots before maintenance needed
5 PCS Ti-alloy made applicator, can fully transfer energy to patients, double efficiency than 1st generation
Can continuously work over 10000 shots without break, so as to provide excellent treatment result
More than 38 pre-set treatment protocols, and support user defined protocols
Energy from 10mJ to 190mJ, adjustable per 10mJ as stepping (equal to 0.25Bar to 5Bar)
Frequency from1Hz to 22Hz, adjustable per 1Hz as stepping
Typical Indications: Radial and ulnar epicondylitis/Tendinitis of the shoulder / shoulder problems/Calcific tendinitis of the shoulder/ Status post muscular injury/Patellar tendinitis/Patellar tendinopathy/Patellofemoral Pain Syndrome/Achillodynia/Plantar fasciitis/Heel spurs (spur in heels)/Myotenositis/Myofascial trigger point therapy e.g. neck/Myofascial trigger point therapy e.g. back, muscular back pain/Sacroiliac joint syndrome/Trochanteric bursitis/Periostitis / shin splints (Condition after overload)/Dupuytren's disease/Thumb basal joint arthritis / rhizarthritis
Extracorporeal shockwave therapy (ESWT) began with an incidental observation of osteoblastic response pattern during animal studies in the mid-1980 that generated an interest in the application of ESWT to musculoskeletal disorders. In the past 10 to 15 years, shockwave therapy had emerged as the leading choice in the treatment of many orthopedic disorders including proximal plantar fasciitis of the heel [1–6], lateral epicondylitis of the elbow [7–10], calcific tendinitis of the shoulder [11, 12] and. non-union of long bone fracture [13–15]. More recently, the use of ESWT had expanded to the treatment of patellar tendinopathy (jumper's knee) and Achilles tendinopathy [16–19], and avascular necrosis of the femoral head [20–22]. ESWT has gained significant acceptance from Europe (Germany, Austria, Italy and others) to South America (Brazil, Columbia, Argentina and others), Asia (Korea, Malaysia, Taiwan and others) and North America (Canada and USA), and this had led to the change of European Society for Musculoskeletal Shockwave Therapy to International Society for Musculoskeletal Shockwave Therapy (ISMST) in 2000. In USA, FDA (Food and Drug Administration) first approved the specific shockwave device, OssaTron (High Medical Technology, Lengwil, Switzerland, now Sanuwave/Alpharetta, GA) for the treatment of proximal plantar fasciitis in 2000 and lateral epicondylitis of the elbow in 2003. FDA also approved Epos (Dornier Medical System, Kennesaw, GA) for the treatment of plantar fasciitis and Sonocur (Siemens Medical Systems, Iselin, NJ) for the treatment of lateral epicondylitis of the elbow in 2002, Orthospec (Medispec, Germantown, MD) and Orbasone (Orthometrix, White Plains, NY) for the treatment of plantar fasciitis in 2005. In the meantime, many off-label uses of ESWT were also studied including calcific tendinitis of the shoulder, patellar tendinopathy, Achilles tendinopathy, and non-union of long bone fracture, avascular necrosis of the femoral head and others. The vast majority of the published papers including randomized control trials and cohort studies showed positive effects and evidence base medicine in favor of ESWT [1–6, 8–12, 23]. However, a few studies reported that ESWT is ineffective or less effective with the results comparable to the placebo effect [7, 24, 25], and this has stirred up the debate and controversy. This article reviews the current status of ESWT in the treatment of musculoskeletal disorders.
Whatsapp/mobile: 0086 13166265196 or 0086 15021573105
Skype : sincery_sales2
Orthopaedic and Sports Medicine Specialists Shock Wave Therapy Device